Excellent R&D experts in Cell2in seek to develop
innovative cell therapy and future medical technology

Field of R&D

Cell2in has established a cell quality management platform technology that can be applied to all areas of cell therapy.
Our technology is primarily focused on 7 different areas.

Cell quality evaluation technology

Cell quality evaluation technology

Measurement of living cells using GSH parameters can be used as a marker to evaluate the quality of cell culture media for enhancing the therapeutic potency.

  • Only high-quality cells can be selected
  • Can be applied to various type of cells Including stem cells and immune cells

Screening of
antioxidant and anti-aging substance

Screening of
antioxidant and anti-aging substance

Rapid discovery of new antioxidant and anti-aging substances by real-time monitoring the glutathione level in living cells using FreSHtracer

  • Can rapidly discover a new lead compound through efficacy evaluation using various cell lines

Development of
serum-free cell culture medium

Development of
serum-free cell culture medium

The development of serum-free medium that is capable of culture the high-quality cells.

  • Can be cultured without heterologous protein additives
  • Overcome the safety limitations of animal components when developing cell therapy, exosome, etc.

Development of
serum-free cryoprotectant

Development of
serum-free cryoprotectant

Development of a cryopreservation that stores the healthy stem cells for a long period and discover the alternative components that do not deteriorate the function of stem cells

  • Replacement of existing heterologous protein components previously used for cryopreservation
  • Stem cells can be safely frozen and directly infused into the body

Mass production of
customized stem cell culture medium

Mass production of
customized stem cell culture medium

Production of customized stem cell culture solution specialized for various diseases with enhanced functions.

  • Selection of culture medium suitable for human tissue-derived stem cells
  • GMP facilities for the mass production of customized culture medium

Production of high-quality
extracellular vesicles and exosomes

Production of high-quality
extracellular vesicles and exosomes

Mass production of extracellular vesicles with enhanced immunosuppressive and anti-inflammatory functions from selected stem cells using proprietary cell quality evaluation technology

  • GMP facilities for separation and purification of high-purity exosomes

Development of
cell quality measuring device

Development of
cell quality measuring device

Development of cell quality management system device equipped with configuration and control system using the FreSHtracer kit

  • Acquisition of a real-time fluorescent cell image
  • Various algorithm composition and data transmission (growth environment composition and image analysis)